Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
Yukiko Yamaguchi, Jackson Gibson, Kevin Ou, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004400-e004400
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
T. R. Chen, Mingzhao Wang, Yanchao Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 37
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 18
Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Jian Chen, Tianchuan Zhu, Guanmin Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
Yongxian Hu, Cheng Zu, Mingming Zhang, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102010-102010
Open Access | Times Cited: 30
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
Lisha Li, Jiaye Lu, Jun Liu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 16
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 725-725
Open Access | Times Cited: 12
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
X. Xia, Zongxin Yang, Qisi Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
Kai Zhang, Yang Mi, Bohao Zhang, et al.
Oncogene (2025)
Closed Access | Times Cited: 1
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 8
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis
Jie Tan, Qianfei Xue, Xiao Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model
Yufei Wang, Jae-Won Cho, Gabriella Kastrunes, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108879-108879
Open Access | Times Cited: 7
Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities
Jiashu Han, Luochu Dong, Mengwei Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma
Ghazaal Roozitalab, Behnaz Abedi, Saber İmani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 889-918
Closed Access | Times Cited: 5
PD-L1 + macrophages suppress T cell-mediated anticancer immunity
Peng Liu, Liwei Zhao, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients
Wenhao An, Changyuan Ren, Lei Yuan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Cold atmospheric plasma restores skewed macrophage polarization in triple negative breast cancers via enhancing KAT6A acetylation
Kaiyuan Zhu, Qing Lv, Xiaoxia Lü, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 4
CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
Eric G. Carlson, Jennifer C. Lopez, Yukiko Yamaguchi, et al.
Research Square (Research Square) (2025)
Closed Access
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors
Wenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
Nature Cancer (2025)
Closed Access
Combination of CAR T cell therapies with immune checkpoint inhibitors
Heather Lin, Dejah Blake, Sarwish Rafiq
Elsevier eBooks (2025)
Closed Access
Integrated analysis of M2 macrophage-related gene prognostic model and single-cell sequence to predict immunotherapy response in lung adenocarcinoma
Meifang Li, Zhiping Wang, Bin Huang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Enhancing Curcumol Delivery through PD-1 Targeted Nanocarriers: A Novel Therapeutic Approach for Prostate Cancer
Hao Zhang, Yang Du, Xujia Liu, et al.
Phytomedicine (2025) Vol. 141, pp. 156595-156595
Closed Access
Using structure-function information from IFN-γ-binding proteins and biased agonists to uncouple immunostimulatory and immunosuppressive activities
Lucas Mendes-Monteiro, Abel Viejo‐Borbolla
Trends in Immunology (2025)
Open Access
Page 1 - Next Page

Scroll to top